Biodelivery Sciences International (BDSI) 14.84

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biodelivery Sciences International (BDSI) 14.84 $BDSI

Next Week In Biotech: Kythera Ad Comm, Roth Conference, Zogenix Earnings
SA Editor Mike Taylor - at Seeking Alpha - Fri Mar 06, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
BDSI: 14.84 (-0.14), OMED: 27.55 (-0.12), BIOA: 9.72 (unch), SUPN: 9.79 (-0.10), CTIC: 2.65 (-0.07), ALXA: 1.99 (+0.02), DSCI: 7.60 (-0.15), ANTH: 6.12 (+0.59), CYTX: 1.11 (-0.05), KYTH: 53.13 (+3.13), ANAC: 47.18 (+0.36), ATHX: 2.98 (+0.10), CRMD: 8.25 (+0.49), ACRX: 8.74 (-0.27), TROV: 6.20 (-0.09), ZGNX: 1.88 (+0.14), PETX: 19.66 (-0.32), RPRX: 9.84 (-0.01), IMUC: 0.59 (-0.01), PGNX: 6.95 (+0.13), SNTA: 2.53 (-0.14), BLCM: 24.48 (+0.13), TXMD: 5.06 (-0.15), OGXI: 2.45 (-0.14), AST: 4.76 (-0.09), PLX: 1.88 (+0.02), ATRS: 2.69 (-0.07)

BioDelivery Sciences to Present at the 27th Annual ROTH Conference
PR Newswire - Tue Mar 03, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 27th Annual ROTH Conference. The presentation is scheduled for Monday, March 9, 2015 at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) at The Ritz-Carlton, Laguna Niguel, in Dana Point, California.
BDSI: 14.84 (-0.14)

How To Beat The Herd Mentality: Highline's Michael Higgins
Life Sciences Report - Seeking Alpha - Thu Feb 26, 2:29PM CST
Michael Higgins of Highline Research Advisors believes it is absolutely vital for a sellside biotech analyst to understand what's going on outside the sector, because no stock lives on an island. The most fabulous fundamentals in the world won't...
BDSI: 14.84 (-0.14), JNJ: 100.11 (-2.41), ESRX: 82.27 (-2.01), PFE: 33.97 (-0.50), PBM: 5.31 (-0.05), GLYC: 8.39 (+0.21), MNKD: 5.47 (-0.26), ALKS: 68.19 (-3.03), PDLI: 6.70 (-0.40)

BioDelivery Sciences earns $10M milestone from Endo
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 12:00PM CST

BDSI: 14.84 (-0.14), ENDP: 87.03 (-0.68)

BioDelivery Sciences to Present at the 2015 RBC Capital Markets Healthcare Conference
PR Newswire - Wed Feb 18, 6:00AM CST
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 2015 RBC Capital Markets Healthcare Conference. The presentation is scheduled for Tuesday, February 24, 2015 at 1:35 p.m. Eastern Time at the New York Palace Hotel in New York City.
BDSI: 14.84 (-0.14)

BioDelivery Sciences Has Returned 12.0% Since SmarTrend Recommendation (BDSI)
Comtex SmarTrend(R) - Mon Feb 09, 10:00AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 3 months, BioDelivery Sciences has returned 12.00% as of today's recent price of $12.80.
BDSI: 14.84 (-0.14)

BioDelivery Signs Agreement with Meda for Onsolis - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 3:07PM CST
BioDelivery (BDSI) entered into an agreement with Meda to obtain marketing authorizations for Onsolis.
BDSI: 14.84 (-0.14), OPHT: 53.19 (-0.29), RGDO: 1.60 (+0.27), CELG: 118.03 (-2.68)

Podcast: Why the biotech boom is still in the 1st inning
ESTMZ - Wed Jan 28, 12:55PM CST
In the latest episode of our weekly podcast,  This Week on Estimize , our CEO Leigh Drogen is joined by Joe McCann, a buy-side biotech analyst and the Founder of Slingshot Insights . Joe tells us why he believes the biotech boom still has plenty...
BDSI: 14.84 (-0.14), GILD: 101.81 (-1.61), RTRX: 15.37 (+1.31), ASPX: 69.14 (-0.32)

BioDelivery Sciences Acquires North American Marketing Authorizations for ONSOLIS from Meda
PR Newswire - Tue Jan 27, 6:00AM CST
BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that it has entered into an assignment and revenue sharing agreement with Meda AB (Meda) under which Meda will transfer the marketing authorizations for ONSOLIS® (fentanyl buccal soluble film, CII) for the United States and the right to seek marketing authorizations for ONSOLIS in Canada and Mexico, back to BDSI. BDSI originally licensed such rights to Meda in 2007, and ONSOLIS was approved by the U.S. Food and Drug Administration (FDA) and originally commercially launched in the United States in 2009.
BDSI: 14.84 (-0.14)

Shares of BDSI Down 18.5% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 22, 9:58AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 2 months, BioDelivery Sciences has returned 18.53% as of today's recent price of $11.85.
BDSI: 14.84 (-0.14)

BioDelivery Sciences International (BDSI) in Focus: Stock Up 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 19, 7:44AM CST
BioDelivery Sciences International, Inc. (BDSI) was a big mover last session, as the company saw its shares gain 5%
BDSI: 14.84 (-0.14), ALXN: 181.65 (-4.14)

BioDelivery Sciences Shares Down 16.8% Since SmarTrend's Sell Call (BDSI)
Comtex SmarTrend(R) - Thu Jan 15, 9:46AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 2 months, BioDelivery Sciences has returned 16.81% as of today's recent price of $12.10.
BDSI: 14.84 (-0.14)

15.8% Return Seen to Date on SmarTrend BioDelivery Sciences Call (BDSI)
Comtex SmarTrend(R) - Wed Jan 07, 11:11AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 2 months, BioDelivery Sciences has returned 15.78% as of today's recent price of $12.25.
BDSI: 14.84 (-0.14)

InsiderInsights.com Daily Round Up 12/30/14: XOMA, ECR, SNCR, AVK
InsiderInsights - at Seeking Alpha - Wed Dec 31, 10:49AM CST

BDSI: 14.84 (-0.14), ECR: 6.51 (-0.06), KFRC: 22.15 (-0.23), EVDY: 12.89 (-0.45), SAM: 257.93 (-2.59), AERI: 28.29 (-0.63), FUND: 7.32 (-0.08), RFMD: 16.59 (-0.35), AVK: 17.10 (-0.25), SNCR: 45.35 (+0.55), FTEK: 3.16 (-0.04), CAS: 3.40 (-0.05), COB: 9.74 (-0.31), XOMA: 3.57 (-0.08), CRM: 64.56 (-1.03)

Downtrend Call Working As BioDelivery Sciences Stock Falls 14.1% (BDSI)
Comtex SmarTrend(R) - Wed Dec 31, 10:00AM CST
SmarTrend identified a Downtrend for BioDelivery Sciences (NASDAQ:BDSI) on November 20th, 2014 at $14.55. In approximately 1 month, BioDelivery Sciences has returned 14.13% as of today's recent price of $12.49.
BDSI: 14.84 (-0.14)

BioDelivery Is A Promising Biotechnology Bet
Value Insight - at Seeking Alpha - Tue Dec 30, 7:29AM CST

BDSI: 14.84 (-0.14), ENDP: 87.03 (-0.68)

Commit To Purchase BioDelivery Sciences International At $10, Earn 24.4% Annualized Using Options
at The Street - Mon Dec 29, 10:35AM CST
Investors considering a purchase of BioDelivery Sciences International Inc stock, but cautious about paying the going market price of $11.86/share, might benefit from considering selling puts among the alternative strategies at their disposal. One...
BDSI: 14.84 (-0.14)

Company News for December 26, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Dec 26, 9:10AM CST
Companies in the News are: CALM,ANFI,ADMS,BDSI
BDSI: 14.84 (-0.14), CALM: 36.27 (-1.02), ADMS: 16.86 (-0.54), ANFI: 10.28 (-0.92)

Endo and BioDelivery Sciences submit NDA for transmucosal pain med
Seeking Alpha - at Seeking Alpha - Thu Dec 25, 11:41AM CST

MNK: 121.33 (-0.37), BDSI: 14.84 (-0.14), ENDP: 87.03 (-0.68), EGLT: 14.05 (-1.13), ZGNX: 1.88 (+0.14), PFE: 33.97 (-0.50), TEVA: 56.40 (-0.11), ABBV: 55.64 (-1.22), ALKS: 68.19 (-3.03), ACUR: 0.75 (-0.03)

Endo/BioDelivery File Regulatory Application for Pain Drug - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Dec 24, 3:45PM CST
Endo International along with its partner BioDelivery Sciences International, Inc. announced the submission of a new drug application for buprenorphine HCl buccal film.
BDSI: 14.84 (-0.14), ENDP: 87.03 (-0.68), AUXL: 36.47 (-0.06), AMGN: 154.88 (-4.72)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 35

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Flexible Packaging Market to Hit $384.32B by 2031

Updated Category News Views 22

Packaging's Flexible Future Alright, here's the skinny: you might want to adjust those portfolios if you're watching the materials sector, because the flexible packaging market ain't just loosening up—it's stretching out like never before. By 2031, we're talking about it raking in a solid $384.32 billion, climbing from $313.25 billion in 2026. That's a not-so-shabby...

Continue Reading
Sue Egstrand to Lead Karo's Next Growth Phase

Updated Category News Views 152

A New Captain at Karo’s Helm Karo Healthcare is bracing for an exciting ride. Sue Egstrand’s appointment as the new CEO pulls the curtain on what might just be a game-changing era for the company. Set to take the wheel on January 1, 2027, Egstrand brings a heavy-hitting resume—a mash-up of pharmaceutical prowess and a deep-dive into consumer healthcare. Sue’s...

Continue Reading
Tammy Keller's Devotional Guides Living with Purpose

Updated Category News Views 77

Finding Meaning in the Dash of Life Life isn’t just bookended by birth and death; it’s the dash in between that counts. If you were sitting next to Tammy Keller right now, you’d probably hear that heartfelt truth straight from her. Her new work, "Your--Dash Devotional," rattles the soul by offering a profound look at making every moment intentional, vivid, and...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 223

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 126

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Jones Soda Expands into Nutrition with UCAN Deal

Updated Category News Views 145

Well, Jones Soda Co. (CSE: JSDA) is stirring the pot with its recent move to acquire the UCAN functional nutrition assets. Popped the news on November 12, 2026, and it turns out they've shelled out a cool $700,000 in cash and taken on $500,000 in liabilities for the privilege. This isn't some casual shuffle of dollars and cents—this one's a strategic gambit aimed at...

Continue Reading
ELEGRP Makes Dyson Supersonic Global Voltage Ready

Updated Category News Views 51

Plugging Into the Future of Travel ELEGRP's latest move brings the Dyson Supersonic Travel hair dryer into the limelight, all decked out with global voltage compatibility. It's like the Swiss Army knife of hair dryers—one minute it’s working on 100V, next it’s flipping over to a juicy 240V, without breaking a sweat. The ALCI Difference: Safety Takes Center Stage...

Continue Reading
Intel Hit by Securities Law Suit Amid PC Market Struggles

Updated Category News Views 5

Intel Faces the Music: Legal Battles Unfold So it seems Intel's got itself in a kettle of fish. The tech giant is being dragged into a courtroom dance, courtesy of a class action lawsuit led by DJS Law Group. Shareholders who snapped up Intel shares between July 23 and October 29, 2026, might be scratching their heads, wondering if they bought into a bit of a mirage. A...

Continue Reading
NVIDIA Faces Fraud Suit: Investors Called to Action

Updated Category News Views 18

NVIDIA and the Quest for Accountability Nothing screams chaos in the market louder than a securities fraud lawsuit hitting the headlines. Investors currently eyeballing NVIDIA Corporation (NASDAQ: NVDA) are in for a wild ride. Yep, you heard it right—NVIDIA is smack in the middle of a class action lawsuit. They're being accused of misleading the market about some shady...

Continue Reading

Top 5 Most Recently Viewed Articles

Fortune Brands' Strategic Moves for Growth and Innovation

Updated Category News Views 506

Fortune Brands Embraces Change for Future Growth Fortune Brands Innovations, Inc. (NYSE: FBIN), a leading innovation company committed to transforming spaces into havens, has announced pivotal changes aimed at enhancing its growth opportunities. These strategic moves reflect the company's dedication to innovation and efficiency as it positions itself for future success....

Continue Reading
Robert Webb's Insightful Stock Options Exercise at NHI

Updated Category News Views 97

Robert Webb Exercises Stock Options at National Health Investors Recently, an important SEC filing revealed that Robert Webb, a Board Member at National Health Investors (NHI), has exercised a significant number of stock options. Key Highlights: The latest Form 4 filing shows that Webb exercised stock options for 70,000 shares of NHI, amounting to a remarkable $1,585,550....

Continue Reading
Palantir Technologies Inc. Increases Investment in UK Defense

Updated Category News Views 271

Palantir Technologies Inc. Stock Update Recently, shares of Palantir Technologies Inc. (NASDAQ: PLTR) saw an increase of 1.58% in pre-market trading following the announcement of a substantial deal with the U.K. government. Strategic Investment in UK Defense This exciting new partnership involves Palantir committing up to £1.5 billion, equivalent to approximately $2...

Continue Reading
Investigation of Varonis Systems, Inc.: A Call to Investors

Updated Category News Views 165

Investigation into Varonis Systems, Inc. Edelson Lechtzin LLP, a well-respected national law firm, is actively investigating Varonis Systems, Inc. (NASDAQ: VRNS) due to potential violations of federal securities laws. This investigation arises from troubling allegations regarding the company's financial disclosures and communication with investors. Varonis Systems,...

Continue Reading
Error Notification on NAV Values in Wealth Invest Fund

Updated Category News Views 127

Error Notification Regarding NAV Values Nasdaq Copenhagen A/S Nikolaj Plads 6 1067 København K Important Information The latest update relates to incorrect NAV values published for the I&T Nordiske Aktier Large Cap division (ISIN: DK0061276656) of Investeringsforeningen Wealth Invest during a specific time frame. Details of the NAV Error This error occurred from 09:45 on...

Continue Reading